Creador in advanced talks to buy 10% of Leeford Healthcare for about ₹800 crore
The proposed investment would value Ludhiana-based Leeford Healthcare, which spans generic drugs, wellness and personal care, at ₹8,000-8,500 crore. If completed, it would mark the company’s first external equity dilution.
Creador is in advanced talks to invest about ₹800 crore for a 10% stake in Ludhiana-based Leeford Healthcare, valuing the pharma, wellness and personal-care company at up to ₹8,500 crore. The deal would be Leeford's first external equity dilution.
Why this matters
No related recent signals are available. The proposed Creador investment would mark Leeford Healthcare's first external equity dilution and place a value on its drugs, wellness and personal-care business.
Retail-company signals are accelerating, up 197,971% QoQ.